Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Harvey A. Risch

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5337-3941; OpenAlex author ID A5006714908, A5110047962, A5138782217; NIH RePORTER profile ID 1888625. Sources: OpenAlex.

Their work

Papers
75 (first author 2, last author 6)
Trials
0
Grants
1
Labs led
1
Collaborators
132
Papers, trials and grants by year

2011: 3 papers · 2012: 5 papers, 1 grant · 2013: 10 papers · 2014: 7 papers · 2015: 11 papers · 2016: 6 papers · 2017: 4 papers · 2018: 3 papers · 2019: 6 papers · 2020: 7 papers · 2021: 5 papers · 2022: 2 papers · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 50 of 75

  1. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  2. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  3. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  4. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  5. Relationship between ABO Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (FUT2) Genotype, but Not Lewis Antigen (FUT3) Genotype. Co-author DOI 10.1158/1055-9965.epi-23-0009↗
  6. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  7. The age-dependent association of risk factors with pancreatic cancer. Co-author DOI 10.1016/j.annonc.2022.03.276↗
  8. Prediction of Pancreatic Cancer in Diabetes Patients with Worsening Glycemic Control. Co-author DOI 10.1158/1055-9965.epi-21-0712↗
  9. A pooled genome-wide association study identifies pancreatic cancer susceptibility loci on chromosome 19p12 and 19p13.3 in the full-Jewish population. Last author DOI 10.1007/s00439-020-02205-8↗
  10. A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. Co-author DOI 10.1016/j.ajhg.2021.09.002↗
  11. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  12. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  13. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Co-author DOI 10.1186/s13073-020-00816-4↗
  14. Incorporating multiple sets of eQTL weights into gene-by-environment interaction analysis identifies novel susceptibility loci for pancreatic cancer. Co-author DOI 10.1002/gepi.22348↗
  15. Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer. Co-author DOI 10.1038/s41467-020-16711-w↗
  16. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  17. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  18. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0091↗
  19. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
  20. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
  21. Current Approaches to Pancreatic Cancer Screening. Co-author DOI 10.1016/j.ajpath.2018.09.013↗
  22. Diabetes and Pancreatic Cancer: Both Cause and Effect. Co-author DOI 10.1093/jnci/djy093↗
  23. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Last author DOI 10.1093/jnci/djy155↗
  24. Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. Co-author DOI 10.1158/1055-9965.epi-18-1235↗
  25. Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer. Last author DOI 10.1186/s12885-019-6250-8↗
  26. Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data. Co-author DOI 10.1371/journal.pone.0218580↗
  27. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  28. Re: NSAID Use and Pancreatic Cancer Risk. Co-author DOI 10.1053/j.gastro.2017.12.053↗
  29. Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study. Co-author DOI 10.1093/carcin/bgy072↗
  30. Aspirin Use and Reduced Risk of Pancreatic Cancer. Co-author DOI 10.1158/1055-9965.epi-16-0508↗
  31. Aspirin and Pancreatic Cancer-Response. Co-author DOI 10.1158/1055-9965.epi-17-0099↗
  32. Low-Dose Aspirin and Pancreatic Cancer Risk-Reply. Co-author DOI 10.1158/1055-9965.epi-17-0208↗
  33. Impact of Sixteen Established Pancreatic Cancer Susceptibility Loci in American Jews. Last author DOI 10.1158/1055-9965.epi-17-0262↗
  34. Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case-control study. Co-author DOI 10.1007/s10552-016-0824-4↗
  35. Association between family cancer history and risk of pancreatic cancer. Co-author DOI 10.1016/j.canep.2016.10.005↗
  36. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Co-author DOI 10.1097/mpa.0000000000000392↗
  37. Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC… Co-author DOI 10.1097/mpa.0000000000000635↗
  38. Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study. Co-author DOI 10.1158/1055-9965.epi-15-1217↗
  39. Exosomes: potential for early detection in pancreatic cancer. First author DOI 10.2217/fon-2015-0005↗
  40. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.29590↗
  41. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis. Co-author DOI 10.1007/s10552-015-0595-3↗
  42. Plasma metabolite biomarkers for the detection of pancreatic cancer. Co-author DOI 10.1021/pr501135f↗
  43. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Co-author DOI 10.1038/ng.3341↗
  44. Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer". Co-author DOI 10.1093/aje/kwv025↗
  45. Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. Co-author DOI 10.1093/aje/kwv026↗
  46. Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium. First author DOI 10.1093/annonc/mdv236↗
  47. Occupational exposure to N-nitrosamines and pesticides and risk of pancreatic cancer. Co-author DOI 10.1136/oemed-2014-102522↗
  48. Vitamin D metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0117574↗
  49. Urinary prostaglandin E2 metabolite and pancreatic cancer risk: case-control study in urban Shanghai. Co-author DOI 10.1371/journal.pone.0118004↗
  50. Correction: vitamin d metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0129983↗

Grants 1

  1. Case Control Study of Pancreas Cancer in Shanghai, China R01CA114421↗

Closest collaborators

The 25 strongest of 132 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Herbert Yu · 21 shared papers, 2011–2020 · strength 0.92
  2. Alison P. Klein · 7 shared papers, 2016–2023 · strength 0.70
  3. Rachel Ε. Neale · 13 shared papers, 2013–2020 · strength 0.68
  4. Lingeng Lu · 10 shared papers, 2011–2019 · strength 0.67
  5. Paige M. Bracci · 15 shared papers, 2011–2022 · strength 0.67
  6. Laufey Thora Amundadottir · 7 shared papers, 2013–2023 · strength 0.65
  7. Steve Gallinger · 14 shared papers, 2011–2022 · strength 0.63
  8. Gloria M. Petersen · 14 shared papers, 2011–2022 · strength 0.59
  9. Sara H. Olson · 11 shared papers, 2011–2021 · strength 0.49
  10. Robert C. Kurtz · 9 shared papers, 2011–2021 · strength 0.44
  11. Eric J. Duell · 11 shared papers, 2011–2020 · strength 0.42
  12. Donghui Li · 7 shared papers, 2014–2020 · strength 0.40
  13. Rachael Z. Stolzenberg‐Solomon · 7 shared papers, 2013–2022 · strength 0.38
  14. Brian Matthew Wolpin · 4 shared papers, 2013–2023 · strength 0.38
  15. Lin Fritschi · 7 shared papers, 2013–2016 · strength 0.35
  16. Samantha A. Streicher · 4 shared papers, 2014–2021 · strength 0.34
  17. Chen Yuan · 2 shared papers, 2022–2023 · strength 0.30
  18. Peter Kraft · 2 shared papers, 2022–2023 · strength 0.30
  19. Mark S. Kidd · 5 shared papers, 2011–2017 · strength 0.30
  20. H. Bas Bueno-de-Mesquita · 10 shared papers, 2011–2016 · strength 0.29
  21. Carlo La Vecchia · 9 shared papers, 2011–2018 · strength 0.28
  22. Yu-Tang Gao · 6 shared papers, 2012–2017 · strength 0.28
  23. Joseph R. Pisegna · 2 shared papers, 2019–2022 · strength 0.25
  24. Christie Y. Jeon · 2 shared papers, 2019–2022 · strength 0.25
  25. Stephen Jacob Pandol · 2 shared papers, 2019–2022 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.